187 related articles for article (PubMed ID: 33096896)
1. NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells.
Quagliariello V; De Laurentiis M; Cocco S; Rea G; Bonelli A; Caronna A; Lombari MC; Conforti G; Berretta M; Botti G; Maurea N
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096896
[TBL] [Abstract][Full Text] [Related]
2. Optimal control strategies for SGLT2 inhibitors as a novel anti-tumor agent and their effect on human breast cancer cells with the effect of time delay and hyperglycemia.
Alblowy AH; Maan N; Ibrahim AA
Comput Biol Med; 2023 Nov; 166():107552. PubMed ID: 37826954
[TBL] [Abstract][Full Text] [Related]
3. Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin.
Efentakis P; Choustoulaki A; Kwiatkowski G; Varela A; Kostopoulos IV; Tsekenis G; Ntanasis-Stathopoulos I; Georgoulis A; Vorgias CE; Gakiopoulou H; Briasoulis A; Davos CH; Kostomitsopoulos N; Tsitsilonis O; Dimopoulos MA; Terpos E; Chłopicki S; Gavriatopoulou M; Andreadou I
Basic Res Cardiol; 2024 Mar; ():. PubMed ID: 38520533
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory cytokines set the stage for cardiac damage.
Ashour D; Ramos G
Cardiovasc Res; 2024 Mar; 120(2):109-110. PubMed ID: 38270957
[No Abstract] [Full Text] [Related]
5. Alterations of DNA damage response genes correlate with response and overall survival in anti-PD-1/PD-L1-treated advanced urothelial cancer.
Joshi M; Grivas P; Mortazavi A; Monk P; Clinton SK; Sue-Ann Woo M; Holder SL; Drabick JJ; Yin M
Cancer Med; 2020 Dec; 9(24):9365-9372. PubMed ID: 33098265
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.
Hegde A; Andreev-Drakhlin AY; Roszik J; Huang L; Liu S; Hess K; Cabanillas M; Hu MI; Busaidy NL; Sherman SI; Dadu R; Grubbs EG; Ali SM; Lee J; Elamin YY; Simon GR; Blumenschein GR; Papadimitrakopoulou VA; Hong D; Meric-Bernstam F; Heymach J; Subbiah V
ESMO Open; 2020 Oct; 5(5):e000799. PubMed ID: 33097651
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer.
Yasuoka S; Yuasa T; Fujiwara R; Komai Y; Numao N; Yamamoto S; Kondo Y; Yonese J
Anticancer Res; 2020 Nov; 40(11):6493-6497. PubMed ID: 33109588
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis.
Leonardi A; Daull P; Garrigue JS; Cavarzeran F; Docquier M; Di Stefano A; Tarricone E; Brun P
Ocul Surf; 2021 Jan; 19():241-248. PubMed ID: 33098984
[TBL] [Abstract][Full Text] [Related]
9. Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer.
Saito Y; Sasaki S; Oikado K; Tominaga J; Sata M; Sakai F; Kato T; Iwasawa T; Kenmotsu H; Kusumoto M; Baba T; Endo M; Fujiwara Y; Sugiura H; Yanagawa N; Ito Y; Sakamoto T; Ohe Y; Kuwano K
Cancer Sci; 2021 Apr; 112(4):1495-1505. PubMed ID: 33098725
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
[TBL] [Abstract][Full Text] [Related]
11. The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice.
Li Z; Murakoshi M; Ichikawa S; Koshida T; Adachi E; Suzuki C; Ueda S; Gohda T; Suzuki Y
FEBS Open Bio; 2020 Dec; 10(12):2761-2770. PubMed ID: 33098615
[TBL] [Abstract][Full Text] [Related]
12. Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.
Charvet E; Kramkimel N; Chaplain L; Gantzer A; Kassem O; Longvert C; Blom A; Dupin N; Aractingi S; Hamon M; Zimmermann U; Emile JF; Sohier P; Sidibé T; Saiag P; Funck-Brentano E
Br J Dermatol; 2021 Apr; 184(4):746-748. PubMed ID: 33098566
[No Abstract] [Full Text] [Related]
13. Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study.
Koshizaka M; Ishikawa K; Ishibashi R; Takahashi S; Sakamoto K; Yokoh H; Baba Y; Ide S; Ide K; Ishikawa T; Onishi S; Kobayashi K; Takemoto M; Horikoshi T; Shimofusa R; Maezawa Y; Yokote K
Diabetes Ther; 2021 Jan; 12(1):183-196. PubMed ID: 33098565
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Molecular and Biological Characteristics of Phyllodes Tumors of the Breast.
Vorotnikov IK; Vysotskaya IV; Denchik DA; Letyagin VP; Davydov MM; Kirsanov VY; Kim EA; Buseva VS
Bull Exp Biol Med; 2020 Oct; 169(6):806-810. PubMed ID: 33098518
[TBL] [Abstract][Full Text] [Related]
15. Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.
Han L; Shi H; Luo Y; Sun W; Li S; Zhang N; Jiang X; Gong Y; Xie C
Cancer Med; 2020 Dec; 9(24):9581-9594. PubMed ID: 33098370
[TBL] [Abstract][Full Text] [Related]
16. Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
von Felden J; Craig AJ; Garcia-Lezana T; Labgaa I; Haber PK; D'Avola D; Asgharpour A; Dieterich D; Bonaccorso A; Torres-Martin M; Sia D; Sung MW; Tabrizian P; Schwartz M; Llovet JM; Villanueva A
Oncogene; 2021 Jan; 40(1):140-151. PubMed ID: 33097857
[TBL] [Abstract][Full Text] [Related]
17. Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetes.
Zhang R; Cai X; Du Y; Liu L; Han X; Liu W; Gong S; Zhou X; Wang X; Wen X; Ji L
J Diabetes Complications; 2021 Jan; 35(1):107750. PubMed ID: 33097385
[TBL] [Abstract][Full Text] [Related]
18. Diabetic Ketoacidosis as a Delayed Immune-Related Event after Discontinuation of Nivolumab.
Mae S; Kuriyama A; Tachibana H
J Emerg Med; 2021 Mar; 60(3):342-344. PubMed ID: 33097350
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.
Quagliariello V; Bonelli A; Caronna A; Conforti G; Iovine M; Carbone A; Berretta M; Botti G; Maurea N
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182653
[TBL] [Abstract][Full Text] [Related]
20. Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients.
Chang WT; Lin YW; Ho CH; Chen ZC; Liu PY; Shih JY
Arch Toxicol; 2021 Feb; 95(2):659-671. PubMed ID: 33211168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
